-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Alamar Biosciences, Raises Price Target to $36

Benzinga·11/04/2026 19:08:03
Diffusion vocale
TD Cowen analyst Dan Brennan maintains Alamar Biosciences (NASDAQ:ALMR) with a Buy and raises the price target from $34 to $36.